What is the appropriate next step in the evaluation and management of suspected endometrial polyps?

Next Course of Action for Suspected Endometrial Polyps

For suspected endometrial polyps, proceed directly to transvaginal ultrasound (TVUS) as the initial diagnostic step, followed by saline infusion sonohysterography (SIS) if a focal endometrial abnormality is identified, and then hysteroscopic polypectomy with histopathological examination for definitive diagnosis and treatment. 1

Diagnostic Algorithm

Step 1: Initial Imaging with Transvaginal Ultrasound

• TVUS is the first-line imaging modality for detecting endometrial polyps in women of reproductive age 2
• Combine with transabdominal ultrasound if the uterus is enlarged or a large tumor is present (limited field of view with TVUS alone) 1
• Accuracy improves with color Doppler, 3D imaging, and contrast enhancement 2

Step 2: Saline Infusion Sonohysterography for Characterization

If TVUS demonstrates a focal endometrial abnormality:

• Perform SIS to further characterize the lesion 1
• SIS achieves 97% pooled accuracy in distinguishing polyps from leiomyomas 1
• Use sterile saline (not gel) as the standard contrast agent 1
• Instill saline at the lowest pressure necessary for adequate visualization 3

Key sonohysterographic features favoring polyp diagnosis:

• Intact myometrial-endometrial interface
• Single feeding vessel
• Acute angle with endometrium
• Homogeneous echogenicity 1

Step 3: Hysteroscopic Evaluation and Treatment

Critical limitation: Neither TVUS nor SIS can reliably distinguish benign polyps from endometrial cancer 1. Therefore:

Endometrial sampling or direct hysteroscopic visualization is mandatory in women with suspected endometrial pathology 1

When to Proceed to Hysteroscopy:

Postmenopausal women:

• All symptomatic polyps (especially with vaginal bleeding) require hysteroscopic polypectomy 2
• Asymptomatic polyps >2 cm or in patients with endometrial cancer risk factors should be removed 2
• Polyps <2 cm in asymptomatic patients without risk factors: individualized approach, but removal preferred given malignancy risk (approximately 3% overall, higher in postmenopausal bleeding) 4

Premenopausal/reproductive-age women:

• All symptomatic polyps (abnormal uterine bleeding, subfertility)
• Asymptomatic polyps in women with endometrial cancer risk factors 2
• Documented polyps in subfertile women planning intrauterine insemination or IVF (improves pregnancy rates) 5

Hysteroscopic Technique Recommendations

Optimal approach for polypectomy:

• Use vaginoscopy as the standard technique (avoids speculum unless cervical dilation needed) 3
• Employ the smallest diameter hysteroscope possible 3
• Mechanical tissue removal systems are preferred over miniature bipolar electrodes for polyp removal 3
• Hysteroscopes with expandable outer working channels cause less pain 3

Pain management:

• Advise oral NSAIDs one hour before the procedure 3
• Local anesthesia not routinely needed for vaginoscopic approach but consider if speculum use or cervical dilation anticipated 3

What NOT to Do

Avoid dilation and curettage (D&C):

• D&C has false-negative rates up to 10% for endometrial cancer 6
• Blind D&C is inaccurate for focal endometrial pathology and should be avoided when hysteroscopy is available 2, 7
• Endometrial biopsy (Pipelle/Vabra) is preferred over D&C for cancer screening but has limited sensitivity for focal lesions like polyps 8, 9

Critical Pitfalls

1. Never assume benign pathology based on imaging alone - malignancy risk exists even in seemingly benign-appearing polyps, particularly in postmenopausal women with bleeding 1, 4

2. Incomplete polyp removal increases recurrence risk - ensure complete hysteroscopic excision with histopathological confirmation 10

3. Don't skip histopathology - tissue diagnosis is mandatory due to malignancy risk (3% overall, higher with risk factors) 2, 4

4. Recognize high-risk features requiring hysterectomy:

   • If histopathology shows atypical hyperplasia or carcinoma within the polyp, hysterectomy is recommended in all postmenopausal patients and premenopausal patients without fertility desires 2

Special Populations

Subfertile women:

• Hysteroscopic polypectomy improves fertility outcomes (RR 2.1 for pregnancy after polypectomy before IUI) 5
• Clinical pregnancy rates after polypectomy range 53-72%; live birth rates 43-66% with IVF/ICSI 5

Asymptomatic premenopausal women:

• Up to 25% of small polyps (<10 mm) may regress spontaneously 4, 7
• Conservative management is an option for small asymptomatic polyps without risk factors, but removal is preferred if risk factors present 2, 4